Heidelberg Engineering, as part of EssilorLuxottica, marked a milestone in global eyecare innovation with the inaugural Visionary Horizons symposium — the first event of its kind showcasing Heidelberg’s pioneering innovation and expertise as a driving force within EssilorLuxottica’s technological and research excellence. The event underscored their shared commitment to advancing ophthalmic science and innovation across the entire eyecare spectrum.
On October 11, 2025, EssilorLuxottica hosted ‘Visionary Horizons: Advancing the Future of EyeCare’, a premier scientific congress that marked a significant milestone in global ophthalmology. Held in collaboration with Heidelberg Engineering, part of the Group since 2024, the groundbreaking event brought together over 100 of the world’s leading ophthalmologists, clinical scientists, and researchers from 20 countries to accelerate the next generation of visual solutions. The symposium, held at the Company’s state-of-the-art Tortona Experience Center in Milan, Italy, served as a crucial platform for expert dialogue, fostering connections and sharing forward-looking insights that are expected to shape the future frontier of eyecare.
The event opened with a welcome address from Francesco Milleri, the Group’s Chairman and CEO, followed by presentations from Norbert Gorny, Chief Scientific Officer, Angelo Arleo, VP, Neuroscience and Medical Research, EssilorLuxottica, and Kfir Azoulay Managing Director, Heidelberg Engineering.
“No company can manage this revolution alone. We must unite to build new collaboration models. Working towards a new dimension, our aim is to create a vertically integrated med-tech platform for the eye, combining early diagnosis, treatments, and ophthalmic surgery. With this integration of scientific research, innovation, AI, clinical data, and practice, we will design new healthcare pathways beyond vision.” Francesco Milleri, Chairman and CEO, EssilorLuxottica
As a cornerstone of EssilorLuxottica’s med-tech strategy, Heidelberg Engineering continues its legacy as a pioneer in diagnostic imaging — now strengthened by the scale, reach, and resources of the broader Group. Together, we are shaping the future of eyecare through collaboration, technology, and clinical insight.
The rigorous scientific agenda was divided into four key sessions:
- Retinal Diseases: The session delved into the intricate patterns of retinal vasculature and the advancements in retinal diagnostics.
- Optic Neuropathies: A discussion on early detection techniques and the integration of AI in glaucoma detection.
- Anterior Segment Disease: A showcase of cutting-edge solutions in refractive surgery, including the latest developments in implantable collamer lenses. It also highlighted modern cataract surgery techniques designed to optimize visual outcomes and patient recovery.
- Myopia: Early intervention strategies and the impact of myopia on the retina.
Looking ahead
Artificial intelligence is a strategic pillar for EssilorLuxottica and Heidelberg Engineering, its innovation leader in diagnostic solutions, digital surgical technologies and healthcare IT for clinical ophthalmology. Together, they empower eyecare professionals and drive improved clinical outcomes, envisioning a future where diagnostic imaging and smart eyewear evolve into intelligent tools that can predict, diagnose, and monitor conditions in real time — transforming eyecare into a more connected and preventive discipline.
